Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction

In this paper, metabolically profiled ST-segment-elevated myocardial infraction (STEMI) patients were randomly assigned a 4-month course of metformin or placebo control.

Results support high-density lipoprotein (HDL) triglyceride concentrations as a predictor for post-MI Left ventricular ejection fraction (LVEF) and infarct size (ISZ). Metformin treatment was found to increase alanine levels and reduce phospholipid content in very large HDL particles.

Stay in the know

Our latest health headlines delivered to your inbox.